Bifidobacterium bifidum (B. bifidum) usually represent the most abundant bacteria in the human intestinal flora of healthy breast-fed infants. It shows significant physiological and genetic characteristics, including adhesion to the epithelium and the metabolism of host-derived glycans. Taking advantage of the specific adaptability of B. bifidum to human intestines and its significance in supporting host health, Creative Biolabs launched the drug discovery service for probiotics B. bifidum.
Author Profile
Latest entries
Tech15/09/2023Lipid nanoparticle development
Tech15/09/2023Functional Liposome Development
Tech15/09/2023Liposomal Formulation
Tech15/09/2023Liposome Development
